Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial - The Lancet Oncology
Keytruda; INN-pembrolizumab
RCSB PDB - 5DK3: Crystal Structure of Pembrolizumab, a full length IgG4 antibody
WO2018204343A1 - Stable formulations of anti-ctla4 antibodies alone and in combination with programmed death receptor 1 (pd-1) antibodies and methods of use thereof - Google Patents
Biomedicines | Free Full-Text | Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa
Frontiers | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer
Chemotherapy Administration Sequencing: An Update on the Current Literature
The Evolving Systemic Treatment for Advanced Hepatocellular Carcinoma | Published in healthbook TIMES Oncology Hematology
Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab | Cell Research
Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
The multiple sequence alignment of known commercial antibodies s used... | Download Scientific Diagram
.png "JAN: Japanese Accepted Names for Pharmaceuticals")
JAN: Japanese Accepted Names for Pharmaceuticals
Addgene: pHR_Gal4UAS_Pembrolizumab_heavychain_T2A_ Pembrolizumab_lightchain_PGK_mCherry
Managing Renal Cell Carcinoma With Pembrolizumab
Biomedicines | Free Full-Text | Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa
WO2017025016A1 - Pd-1 antibodies - Google Patents
SILu™Lite SigmaMAb Pembrolizumab Monoclonal Antibody recombinant, expressed in CHO cells | Sigma-Aldrich
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab | springermedizin.de
Sequential pembrolizumab may be optimal timing with chemoradiotherapy in head/neck cancer
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy - ScienceDirect
Electrostatic potential map of Pembrolizumab (sequence 5DK3, PDB)... | Download Scientific Diagram
Biomedicines | Free Full-Text | Analysis of Pembrolizumab in Human Plasma by LC-MS/HRMS. Method Validation and Comparison with Elisa
Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab - The Lancet Oncology
Sequence comparison of the antibodies against PD-L1. The CDRs are... | Download Scientific Diagram
